Lauren M Hynicka

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. doi request reprint Anemia management in patients with chronic viral hepatitis C
    Lauren M Hynicka
    School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Ann Pharmacother 47:228-36. 2013
  2. doi request reprint Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients
    Lauren M Hynicka
    School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Ann Pharmacother 46:558-66. 2012
  3. doi request reprint Probable rifaximin-induced neutropenia
    Lauren M Hynicka
    University of Maryland School of Pharmacy, 20 North Pine Street, Baltimore, MD 21201, USA
    Am J Health Syst Pharm 69:583-6. 2012
  4. doi request reprint A review of oral antiretroviral therapy for the treatment of chronic hepatitis B
    Lauren M Hynicka
    School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    Ann Pharmacother 44:1271-86. 2010

Collaborators

Detail Information

Publications4

  1. doi request reprint Anemia management in patients with chronic viral hepatitis C
    Lauren M Hynicka
    School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Ann Pharmacother 47:228-36. 2013
    ..To review the literature regarding current strategies for the management of anemia associated with treatment for chronic viral hepatitis C (HCV) in adults...
  2. doi request reprint Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients
    Lauren M Hynicka
    School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Ann Pharmacother 46:558-66. 2012
    ..To review the literature regarding current strategies and strategies under active development for the prevention and treatment of respiratory syncytial virus (RSV) infections in immunocompromised adults...
  3. doi request reprint Probable rifaximin-induced neutropenia
    Lauren M Hynicka
    University of Maryland School of Pharmacy, 20 North Pine Street, Baltimore, MD 21201, USA
    Am J Health Syst Pharm 69:583-6. 2012
    ..The development of neutropenia in a patient treated with rifaximin is reported...
  4. doi request reprint A review of oral antiretroviral therapy for the treatment of chronic hepatitis B
    Lauren M Hynicka
    School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    Ann Pharmacother 44:1271-86. 2010
    ..To describe the current evidence for the use of oral antiretroviral (ARV) agents in the treatment of chronic hepatitis B (CHB)...